We are live on ! Find out more
BBLGW

Bone Biologics Corp Warrants
BBLGW

3 hedge funds and large institutions have $3.11K invested in Bone Biologics Corp Warrants in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% less funds holding

Funds holding: 5 → 3 (-2)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

93% less capital invested

Capital invested by funds: $42K → $3.11K (-$38.9K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$7

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$3.53K
2
SM
Sabby Management
Florida
-$60
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.89K -$60 -33 -0.9%
WAM
2
Warberg Asset Management
Illinois
$1.22K -$3.53K -1,945 -59%
CS
3
Clear Street
New York
– +$7 +4 +0.5%

BBLGW Hedge Fund Activity: Q4 2022 in Review

3 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Bone Biologics Corp Warrants (BBLGW) for Q4 2022, worth a combined $3.11K — down 93% from $42K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BBLGW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Clear Street, adding an estimated $7. The largest seller was Warberg Asset Management, cutting an estimated $3.53K.

  • 3 institutional investors held Bone Biologics Corp Warrants (BBLGW) as of Q4 2022, down from 5 in Q3 2022.
  • Funds reported $3.11K of Bone Biologics Corp Warrants stock for Q4 2022, down 93% quarter-over-quarter.
  • 0 funds opened new Bone Biologics Corp Warrants positions in Q4 2022 and 1 closed out, a net change of -1 holder.
  • The largest Bone Biologics Corp Warrants buyer in Q4 2022 was Clear Street, an estimated $7 added.
  • The largest Bone Biologics Corp Warrants seller in Q4 2022 was Warberg Asset Management, an estimated $3.53K sold.

Based on aggregated 13F filings for Q4 2022.